Physician

Nallathamby Thayapran, M.D.

According to 2025 Medicare claims, Nallathamby Thayapran, M.D. (NPI: 1386740421) practices cardiology in the Visalia, CA market, with the plurality of this provider's patient population coming from Tulare, CA. This provider's primary affiliated billing organization is NALLATHAMBY THAYAPRAN, MD, INC. (NPI: 1154472785; TIN: 205362220) and primary practice location at 93257-3146.

Thayapran's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,001 traditional Medicare patients, billed 12,371 HCPCS/CPT codes, and received $3,600,285 in Medicare payments. The top billing code was 78492 (Nuclear medicine studies of blood flow in heart muscle at rest and with stress). Part D data shows 3,169 prescription claims across 563 beneficiaries totaling $518,163 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 11 claims. Open Payments data shows 1 records totaling $62. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,945,489 to $3,600,285. Similarly, Part D prescription costs have moved sharply higher in recent years, from $157,545 to $518,163. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $6,304 and ending at $534.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,620	14,895	$1,945,489
2016	2,568	15,628	$2,177,088
2017	2,558	15,796	$2,350,122
2018	1,862	13,698	$2,548,007
2019	1,350	11,611	$3,206,554
2020	1,232	11,883	$3,897,455
2021	1,142	12,549	$3,889,980
2022	1,094	12,421	$3,623,488
2023	1,031	11,805	$3,301,595
2024	1,001	12,371	$3,600,285

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	536	3,595	$157,545
2016	579	3,786	$159,683
2017	624	4,095	$236,445
2018	603	4,064	$254,214
2019	533	3,259	$262,934
2020	522	2,850	$292,970
2021	531	2,933	$312,784
2022	532	2,994	$437,828
2023	515	2,876	$507,457
2024	563	3,169	$518,163

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	22	$1,367
2016	N/R	46	$2,042
2017	N/R	17	$948
2018	N/R	44	$2,111
2019	N/R	41	$1,662
2020	N/R	30	$1,460
2021	N/R	11	$589
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78492	Nuclear medicine studies of blood flow in heart muscle at rest and with stress	547	552	$1,284
A9555	Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries	547	1,104	$433
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	614	641	$147
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	684	2,397	$101
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	655	1,014	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	203	12,570	$245,472
Xarelto	Rivaroxaban	72	5,655	$104,250
Brilinta	Ticagrelor	57	3,615	$48,371
Entresto	Sacubitril/Valsartan	37	2,415	$43,570
Jardiance	Empagliflozin	20	1,500	$26,632

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$62	Penumbra, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nallathamby Thayapran, M.D.?

Tedicare shows public-source Medicare data for Nallathamby Thayapran, M.D. (NPI 1386740421), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nallathamby Thayapran, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nallathamby Thayapran, M.D.?

Nallathamby Thayapran, M.D. is linked to NALLATHAMBY THAYAPRAN, MD, INC. (billing NPI 1154472785) in the available physician profile data.

Does Nallathamby Thayapran, M.D. have Open Payments data?

Nallathamby Thayapran, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.